BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 2017
View Archived Issues
Bayer and DKFZ disclose novel AhR antagonists for cancer
Read More
New rat model captures characteristics of AKT3 hemimegencephaly
Read More
Principia Biopharma begins clinical studies of PRN-1008 in ITP
Read More
Novel alphaVbeta3 antagonists show promise for osteoporosis
Read More
UMN Pharma returns influenza vaccine program rights to Protein Sciences
Read More
Allakos secures series B financing to advance its development programs
Read More
New formulation of Oncaspar approved in Europe
Read More
X-Chem enters research collaboration with Abilita Bio
Read More
reMYND and Novo Nordisk enter license agreement for ReS-39 in diabetes
Read More
FDA approves Pfizer's infliximab biosimilar Ixifi
Read More
Targeting potassium channel Kv7.2 may improve Dravet syndrome
Read More
Glenmark Pharmaceuticals' phase III study of Ryaltris meets primary endpoint
Read More
NIH grant supports IBBR's research into the TCR signaling mechanism
Read More
Positive first-in-human data for new complement C3 inhibitor AMY-10
Read More
Novel mutation in PIGQ gene tied to epileptic encephalopathy
Read More
Bristol-Myers Squibb and Ono Pharmaceutical sign license agreement for ONO-4578
Read More
JCR reports topline results from phase I/II study of JR-141 in Hunter's syndrome
Read More
Meiji and Kaketsuken to enter into memorandum of understanding regarding new company
Read More
Novel PD-1 signaling inhibitors presented by Institute of Materia Medica of Beijing
Read More
Institute of Materia Medica of Beijing divulges salinomycin oxime ether derivatives
Read More
SLC22A12 inhibitors described in Institute of Materia Medica of Beijing patent
Read More
Scancell and Cancer Research UK partner to progress SCIB-2 into phase I/II study
Read More
Idera Pharmaceuticals patents antisense oligonucleotides for cancer
Read More
Vertex enters development agreement with CRISPR Therapeutics for gene-editing treatment
Read More